{
  "directed": true,
  "graph": {
    "annotation_list": {},
    "annotation_pattern": {},
    "annotation_url": {
      "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno"
    },
    "document_metadata": {
      "authors": "Esther Wollert",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "copyright": "Copyright © 2018 Fraunhofer Institute SCAI, All rights reserved",
      "description": "",
      "licenses": "CC BY 4.0",
      "name": "Alpha-synuclein oligomers: a new hope ",
      "version": "1.0.0"
    },
    "namespace_pattern": {},
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/terminology/1b20f0637c395f8aa89c2e2e342d7b704062c242/external/chebi-names.belns",
      "CONSO": "https://raw.githubusercontent.com/pharmacome/conso/501ceccdc9a27d97edbdc48a89ebe8e1dd3626e9/export/conso.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/terminology/1b20f0637c395f8aa89c2e2e342d7b704062c242/external/go-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/1b20f0637c395f8aa89c2e2e342d7b704062c242/external/hgnc-symbols.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/1b20f0637c395f8aa89c2e2e342d7b704062c242/external/mesh-names.belns"
    },
    "namespaces_uncached": [],
    "path": "snca/bengoa2017.bel",
    "pybel_version": "0.13.2"
  },
  "links": [
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "name": "Acta neuropathologica",
        "pages": "819-838",
        "reference": "28803412",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "type": "PubMed",
        "volume": "134"
      },
      "evidence": "Over the past two decades, the pre-synaptic protein alphasynuclein (a-syn) has been irrefutably tied to the neurodegenerative disorder Parkinson’s disease.",
      "key": "c91387987265f251e00ef9ee912b059a071f54401aabdc6213729b0f022ecb38af7918d873e388df6a2ae7e130ebe83c9e106c0915a5a40bfd068179ffa1a1fa",
      "line": 38,
      "relation": "association",
      "source": 33,
      "target": 47
    },
    {
      "key": "be326115b03b23c8f9535c21a847d21c9d71e9ca0a6e59ec5908fdafce0eaeeec33010beead981cf64164710a885bfd84590f8605663c0c087fcfebbf7ab6580",
      "relation": "hasVariant",
      "source": 33,
      "target": 36
    },
    {
      "key": "d7fd63af4e3f7cfae7a2b90e0640eb9e32d7d438c80a40b935d1b4c063e700a98f91942bafcfb9e978093c0c678b1875a13dc8e6ce459a7df6f0dedb0be84748",
      "relation": "hasVariant",
      "source": 33,
      "target": 34
    },
    {
      "key": "aa1cd1b1fde5819fffb3bd274592ccce1d2ee7acd6a99c98ef1fad0adeda7dc633412e77345238b3db54cf10af5d5a356d6bf5c157e1dc23744b18a0f7ff7345",
      "relation": "hasVariant",
      "source": 33,
      "target": 37
    },
    {
      "key": "d3f6784550109a7129f4c01b5a89f80a55d77d327234c87051f26347b83a04d196f5e486f9a99366c477cd5c4853be14aa7417fc60d0b8458c555e779797c61d",
      "relation": "hasVariant",
      "source": 33,
      "target": 39
    },
    {
      "key": "b4f96c3cc830cb9e0e81f63db348b1b62a27c714fe45a603cb3f6ca7cbe7eaedabd54a59877326d464b92464037e3baf2373ef606d0af3a165ac1a29daa76c76",
      "relation": "hasVariant",
      "source": 33,
      "target": 38
    },
    {
      "key": "c5cc4105fbe412fa9cad8c8e877d365621e80493f903f43c2bcbc85f349449cc556534f5e59ca1c2aeab80ac1ba5a6fc6efaffb77a78f5a91a760c8dc3dbb2e6",
      "relation": "hasVariant",
      "source": 33,
      "target": 35
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "name": "Acta neuropathologica",
        "pages": "819-838",
        "reference": "28803412",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "type": "PubMed",
        "volume": "134"
      },
      "evidence": "Over the past two decades, the pre-synaptic protein alphasynuclein (a-syn) has been irrefutably tied to the neurodegenerative disorder Parkinson’s disease.",
      "key": "3787278b91bd2e557ee96e5e7fd389c872d00679a66ba63221dcd51b4fb6939d010eb5fece52a2bc1f63dc64203fa996f63e5195dbadf6f340b4f235a452e06d",
      "line": 38,
      "relation": "association",
      "source": 47,
      "target": 33
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true,
          "Cerebrospinal Fluid": true,
          "Serum": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "name": "Acta neuropathologica",
        "pages": "819-838",
        "reference": "28803412",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "type": "PubMed",
        "volume": "134"
      },
      "evidence": "Elevated levels of a-syn oligomers were found in PD patients compared to controls or AD patients in brain homogenate, CSF and serum.",
      "key": "1bc869d3e80a9ddfc2b900cf2d5951bfb2d9d7b1b8be1f3db29f92316f2af20732abd7a89cbfa6e8f1cc0f35037b0d87844c92c754974dc1fa209e4705a0a08a",
      "line": 194,
      "relation": "positiveCorrelation",
      "source": 47,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "name": "Acta neuropathologica",
        "pages": "819-838",
        "reference": "28803412",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "type": "PubMed",
        "volume": "134"
      },
      "evidence": "the point mutation in SNCA (A53T) was demonstrated to cause autosomal dominant Parkinson’s disease [126] and several other point mutations (A30P, E46K, H50Q, G51D and A53E) have since been shown to cause familial forms of Parkinson’s disease and dementia with Lewy bodies (DLB) [4, 79, 84, 119, 129, 167].",
      "key": "e1c61da3dff2a292490e649ebecc373ecd02814d9f7cb3d12c16d848db824814f0bbe964fdc1cf84fa5963f89bf59cb2a3748d13b32228ee98137092d5e611d7",
      "line": 44,
      "relation": "increases",
      "source": 36,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "name": "Acta neuropathologica",
        "pages": "819-838",
        "reference": "28803412",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "type": "PubMed",
        "volume": "134"
      },
      "evidence": "the point mutation in SNCA (A53T) was demonstrated to cause autosomal dominant Parkinson’s disease [126] and several other point mutations (A30P, E46K, H50Q, G51D and A53E) have since been shown to cause familial forms of Parkinson’s disease and dementia with Lewy bodies (DLB) [4, 79, 84, 119, 129, 167].",
      "key": "4a396c61f6812a2c01d47da3653dd8933f16584d0bf5b0f2b177906af07dc561313d1bfe4639e89bf982172cd81a2012f95d155b180b88abed9633e0bd0f77e3",
      "line": 45,
      "relation": "increases",
      "source": 34,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "name": "Acta neuropathologica",
        "pages": "819-838",
        "reference": "28803412",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "type": "PubMed",
        "volume": "134"
      },
      "evidence": "the point mutation in SNCA (A53T) was demonstrated to cause autosomal dominant Parkinson’s disease [126] and several other point mutations (A30P, E46K, H50Q, G51D and A53E) have since been shown to cause familial forms of Parkinson’s disease and dementia with Lewy bodies (DLB) [4, 79, 84, 119, 129, 167].",
      "key": "41d57aafc0860b32903972ec3927483575b3537cf49dd35a8a1efad084bff88032d19143d5355a7d72e97c375356328074fc7ff132f50c2f2d12277342c770b1",
      "line": 46,
      "relation": "increases",
      "source": 34,
      "target": 45
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "name": "Acta neuropathologica",
        "pages": "819-838",
        "reference": "28803412",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "type": "PubMed",
        "volume": "134"
      },
      "evidence": "the point mutation in SNCA (A53T) was demonstrated to cause autosomal dominant Parkinson’s disease [126] and several other point mutations (A30P, E46K, H50Q, G51D and A53E) have since been shown to cause familial forms of Parkinson’s disease and dementia with Lewy bodies (DLB) [4, 79, 84, 119, 129, 167].",
      "key": "ab843f6c953bf063d7891318006e3a2d1b93e932b3f70f244034432055c61b6d42075bf22725b7a4e77e7268be5d88f6ef3c86627bb7914e108e0a30b2c2f888",
      "line": 47,
      "relation": "increases",
      "source": 37,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "name": "Acta neuropathologica",
        "pages": "819-838",
        "reference": "28803412",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "type": "PubMed",
        "volume": "134"
      },
      "evidence": "the point mutation in SNCA (A53T) was demonstrated to cause autosomal dominant Parkinson’s disease [126] and several other point mutations (A30P, E46K, H50Q, G51D and A53E) have since been shown to cause familial forms of Parkinson’s disease and dementia with Lewy bodies (DLB) [4, 79, 84, 119, 129, 167].",
      "key": "696953ecc2673ed0af592001d88571cb1eb5f64f2cf1951cce3f8d8acfdd238dbf474401cf25198972b35512515a8ff18d33f09807ac7760ce15a8dcbe99a2bb",
      "line": 49,
      "relation": "increases",
      "source": 39,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "name": "Acta neuropathologica",
        "pages": "819-838",
        "reference": "28803412",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "type": "PubMed",
        "volume": "134"
      },
      "evidence": "the point mutation in SNCA (A53T) was demonstrated to cause autosomal dominant Parkinson’s disease [126] and several other point mutations (A30P, E46K, H50Q, G51D and A53E) have since been shown to cause familial forms of Parkinson’s disease and dementia with Lewy bodies (DLB) [4, 79, 84, 119, 129, 167].",
      "key": "6173a17a8863be33f180e55864b372af757aa4245752e444631124af7daba49f6dd22800101b5163d4a9802c8a7dd0069509367cbd435aedd289ee66e01ad736",
      "line": 51,
      "relation": "increases",
      "source": 38,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "name": "Acta neuropathologica",
        "pages": "819-838",
        "reference": "28803412",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "type": "PubMed",
        "volume": "134"
      },
      "evidence": "the point mutation in SNCA (A53T) was demonstrated to cause autosomal dominant Parkinson’s disease [126] and several other point mutations (A30P, E46K, H50Q, G51D and A53E) have since been shown to cause familial forms of Parkinson’s disease and dementia with Lewy bodies (DLB) [4, 79, 84, 119, 129, 167].",
      "key": "eaa88491cbb10ff4dc8427a3fc4ebfe33a1fde14b0c932893fd96f6f8a485f0e47b3e338350388e4cbbd85bb05f323d729545f38adcd4dafbad76dc853a60185",
      "line": 53,
      "relation": "increases",
      "source": 35,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "name": "Acta neuropathologica",
        "pages": "819-838",
        "reference": "28803412",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "type": "PubMed",
        "volume": "134"
      },
      "evidence": "Not only did this discovery draw attention to aggregated forms of a-syn as mediators of Parkinson’s disease pathogenesis, but also opened the door to the use of a-syn detection techniques for diagnosis and staging.",
      "key": "6eed9cafa1fb2d28e74cf28703b969c74c9b619dea815dddc31b9883ac123fea15950616595f67045e14caedb9b5a263746d44b472ce9634d21beb328a5e7edf",
      "line": 59,
      "relation": "increases",
      "source": 5,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "name": "Acta neuropathologica",
        "pages": "819-838",
        "reference": "28803412",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "type": "PubMed",
        "volume": "134"
      },
      "evidence": ". Multiple lines of evidence now suggest that oligomeric species of a-syn, which are thought to precede the fibrillar aggregates found in Lewy bodies, are the culprits for neuronal degeneration in Parkinson’s disease",
      "key": "78375cbed316720930168d7e7cf1f80b967aecc022be692a605d50aad0218340fd79882bbb18169bc4d5374c348c46bd2a7075f5b1ae6ad32489714f8b0c5400",
      "line": 64,
      "relation": "increases",
      "source": 9,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Microglia": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "name": "Acta neuropathologica",
        "pages": "819-838",
        "reference": "28803412",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "type": "PubMed",
        "volume": "134"
      },
      "evidence": " Oligomeric detection may have uses as a diagnostic biomarker, as a biomarker of the progression of the disease, and in the future, perhaps as an index of response to novel therapies. ",
      "key": "4a6b0d5d4f7104fc0e83986710707b7abec2dd8c0e1799fb7cdad0db5d8f3f9ee82f1e0a00e65aae3f0879b85203c6318b7329c253d1ace509a2d51e4825fe01",
      "line": 189,
      "relation": "biomarkerFor",
      "source": 9,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true,
          "Cerebrospinal Fluid": true,
          "Serum": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "name": "Acta neuropathologica",
        "pages": "819-838",
        "reference": "28803412",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "type": "PubMed",
        "volume": "134"
      },
      "evidence": "Elevated levels of a-syn oligomers were found in PD patients compared to controls or AD patients in brain homogenate, CSF and serum.",
      "key": "a3ef58c25aeef52a27509f19ea97ccf080eaa780f6e0385fb2924a4db8b3cf5d35c77394a68535c2940cab8dc9d2bab55df25dd8c91a3845b10d735d49243745",
      "line": 194,
      "relation": "positiveCorrelation",
      "source": 9,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "name": "Acta neuropathologica",
        "pages": "819-838",
        "reference": "28803412",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "type": "PubMed",
        "volume": "134"
      },
      "evidence": ". Multiple lines of evidence now suggest that oligomeric species of a-syn, which are thought to precede the fibrillar aggregates found in Lewy bodies, are the culprits for neuronal degeneration in Parkinson’s disease",
      "key": "2c2e3411c316fc712ff596c2e2fd93d425c0a9fdd78a50fbf2c321f9419db8858969be5d40353ad88da942442bdeff55cda409fb7c6abfba529c9b9b043f7a8d",
      "line": 65,
      "relation": "increases",
      "source": 9,
      "target": 8
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "name": "Acta neuropathologica",
        "pages": "819-838",
        "reference": "28803412",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "type": "PubMed",
        "volume": "134"
      },
      "evidence": " In vitro formed a-syn oligomers ectopically applied to cell cultures or formed due to overexpression of a-syn induce cell death [20, 30, 109, 149], which has been recapitulated in vivo in several studies.",
      "key": "35860b6300f458cc95e0a77e186b3e9960fa5989bff676a75bff23bdc6ec866b6bd624f683b13839c8c2de26546f882ffd2dbf27488adf33a4a44754f53578b3",
      "line": 76,
      "relation": "increases",
      "source": 9,
      "target": 17
    },
    {
      "annotations": {
        "Cell": {
          "neuron": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "name": "Acta neuropathologica",
        "pages": "819-838",
        "reference": "28803412",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "type": "PubMed",
        "volume": "134"
      },
      "evidence": " In contrast, a-syn 30–110 that forms fibrils at a fast rate, did not display toxicity, indicating that oligomers are indeed the toxic species leading to TH-neuron loss in vivo [162].",
      "key": "63b3032a80ad0b62d38fce7f4c7b45f6f16473fa15d33164a68d4e366c5ffa72ebbf0d9f9dc4d796621852aa1ea2e42c288ef6b8dfef0872c70c73ab9cbabb73",
      "line": 82,
      "relation": "increases",
      "source": 9,
      "target": 17
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "name": "Acta neuropathologica",
        "pages": "819-838",
        "reference": "28803412",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "type": "PubMed",
        "volume": "134"
      },
      "evidence": "In 2014 Plotegher et al. showed that mitochondrial morphology is disrupted by a-syn oligomers, which cause fragmentation of these organelles in vitro in SH-SY5Y cells [124]. ",
      "key": "a1750998125b6ec1b12fd960b08daf36b0dc9d11eb6d07aa846df629a7571bec29262ab44a2d23432e89c0519dcb73e1fa5388fd208d33319f013102e77ea029",
      "line": 89,
      "relation": "decreases",
      "source": 9,
      "target": 15
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "name": "Acta neuropathologica",
        "pages": "819-838",
        "reference": "28803412",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "type": "PubMed",
        "volume": "134"
      },
      "evidence": "All these results show that a-syn oligomers are implicated in mitochondrial dysfunction across different models.",
      "key": "842b24cfa83e82ccc7707f479fb15ad31e9f88242b1d58ff2d66e791eb6449a604f13881d3fd75f970165fa0484978d4b7e8da019fcabbca741ca91f72d627da",
      "line": 98,
      "relation": "increases",
      "source": 9,
      "target": 44
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "name": "Acta neuropathologica",
        "pages": "819-838",
        "reference": "28803412",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "type": "PubMed",
        "volume": "134"
      },
      "evidence": "Accumulation of oligomers has been demonstrated in a transgenic mouse overexpressing A53T a-syn and in Parkinson’s disease brain tissue, resulting in chronic ER stress and impaired ER protein quality control [25].",
      "key": "6c238265a5ac2f8dd05b49e6ec6b94ea7ab5ecd79b9c6cc936dfc79f0757865324e4ed57fd68c4188da4296bdd9cb3b3078090239b1f66209da380ad17e2226c",
      "line": 103,
      "relation": "increases",
      "source": 9,
      "target": 23
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Endoplasmic Reticulum": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "name": "Acta neuropathologica",
        "pages": "819-838",
        "reference": "28803412",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "type": "PubMed",
        "volume": "134"
      },
      "evidence": " This can be inhibited by a-syn oligomers: oligomers were shown to inhibit proteasomal activity, which was blocked by addition of antibodies that neutralized the interaction [87]. ",
      "key": "719609562b24b2cb966866374ef336ccf1df7ef066f84e7e89fd5fbec18e414e8138e2c8b8537213f965a6d4bddf69af27cd800be62b185b8fec62e702478cdf",
      "line": 114,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 9,
      "target": 24
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Microglia": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "name": "Acta neuropathologica",
        "pages": "819-838",
        "reference": "28803412",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "type": "PubMed",
        "volume": "134"
      },
      "evidence": " However, in a different report, oligomers were shown to activate proinflammatory signals in microglial cells in vitro and in vivo, and this was prevented by addition of a MAP kinase inhibitor [161].",
      "key": "c86af7bfbd1051b1be7d142c1fd1961cb0563cabab9b79e772b9680197e2e0666e87a8ce5a27b07d7a798c291515ef5d43a79dbe897c1f9cbc39a60ee09c8330",
      "line": 131,
      "relation": "increases",
      "source": 9,
      "target": 20
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Microglia": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "name": "Acta neuropathologica",
        "pages": "819-838",
        "reference": "28803412",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "type": "PubMed",
        "volume": "134"
      },
      "evidence": " Kim et al. demonstrated that a-syn oligomers lead to microglial inflammatory responses via TLR2 activation [74].",
      "key": "e3b386f47340eb60f13dab85d8a68b4348b90f4f08f6dab6458925fbd406dd492a2aa106c048fda9408f6a426e1b26484a9e6b896fe2665c93e1be593d28e358",
      "line": 136,
      "relation": "increases",
      "source": 9,
      "target": 19
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Microglia": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "name": "Acta neuropathologica",
        "pages": "819-838",
        "reference": "28803412",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "type": "PubMed",
        "volume": "134"
      },
      "evidence": " Kim et al. demonstrated that a-syn oligomers lead to microglial inflammatory responses via TLR2 activation [74].",
      "key": "f4631281f8600de695aee1d770a5ee9055f1181cada803fb4bdef92731029114e0d8539d9bda9824260dc99b31fc2da8c57f150358d469e0382e7e06007d18d8",
      "line": 137,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 9,
      "target": 41
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Microglia": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "name": "Acta neuropathologica",
        "pages": "819-838",
        "reference": "28803412",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "type": "PubMed",
        "volume": "134"
      },
      "evidence": " Another report by Zhang and collaborators also highlighted glial activation and production of reactive oxygen species in response to oligomer-like preparations of aggregated a-syn [168]. ",
      "key": "a30ad02ca419052a86c38061f5a7ecee2b48ac9caf1ac41e574f128498508337d28e2ccaa9f44397480420dcb6d79507d0aee6abb62cebc8834a51bdc48483d3",
      "line": 142,
      "relation": "increases",
      "source": 9,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Microglia": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "name": "Acta neuropathologica",
        "pages": "819-838",
        "reference": "28803412",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "type": "PubMed",
        "volume": "134"
      },
      "evidence": "A-syn oligomers can stabilize membrane defects accelerating membrane damage [19] and can alter membrane properties such as input resistance reducing neuronal excitability [72]",
      "key": "1ff6b4b84580f203e50390eb3bace87513375d5d4e9e3494947e2c93b6e7edd13de86136b599cd4e651a4966a7f7b3bf577c46d9891f070dcd21e2c76b2e32a9",
      "line": 147,
      "relation": "decreases",
      "source": 9,
      "target": 11
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Microglia": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "name": "Acta neuropathologica",
        "pages": "819-838",
        "reference": "28803412",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "type": "PubMed",
        "volume": "134"
      },
      "evidence": "Dysfunctional membranes can also have an important impact on calcium homeostasis; some types of oligomers can lead to a cytotoxic calcium influx presumably by building pore-like structures [30]. ",
      "key": "7269844fb59d430dd30708e689b8624b10cde0cbaf8a671061ecb97ed4afc0d8f90e539e61bf0e55a18e2b1facadecd9c8985bfa49004d2c55666cf8bda6426b",
      "line": 152,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "extracellular space",
            "namespace": "GO"
          },
          "toLoc": {
            "name": "intracellular part",
            "namespace": "GO"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 9,
      "target": 1
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Microglia": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "name": "Acta neuropathologica",
        "pages": "819-838",
        "reference": "28803412",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "type": "PubMed",
        "volume": "134"
      },
      "evidence": "The trafficking of synaptic vesicles may also be negatively impacted by a-syn oligomers, which have been shown to decrease axonal transport by decreasing microtubule stability and impairing the interaction between kinesin and microtubules [128], as well as inhibiting tubulin polymerisation [20]. ",
      "key": "77bc35f6cfe1b06983bef7acd316c646ebcb1d3b8d8c39a8ab3037a6c50f0e6a113b95ced206cc9e2478e142551e29afd73605630ca1e9526a00147fb200ed4f",
      "line": 173,
      "relation": "decreases",
      "source": 9,
      "target": 21
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Microglia": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "name": "Acta neuropathologica",
        "pages": "819-838",
        "reference": "28803412",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "type": "PubMed",
        "volume": "134"
      },
      "evidence": "The trafficking of synaptic vesicles may also be negatively impacted by a-syn oligomers, which have been shown to decrease axonal transport by decreasing microtubule stability and impairing the interaction between kinesin and microtubules [128], as well as inhibiting tubulin polymerisation [20]. ",
      "key": "478536d58cd2137d488c70338d05d29a533cd6de156008026d0b15ffc483f14aefa09e7d20b7c48f3b028df8ea4f84fc71abf58d30f6706757035cf32ec35422",
      "line": 174,
      "relation": "decreases",
      "source": 9,
      "target": 18
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Microglia": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "name": "Acta neuropathologica",
        "pages": "819-838",
        "reference": "28803412",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "type": "PubMed",
        "volume": "134"
      },
      "evidence": "The trafficking of synaptic vesicles may also be negatively impacted by a-syn oligomers, which have been shown to decrease axonal transport by decreasing microtubule stability and impairing the interaction between kinesin and microtubules [128], as well as inhibiting tubulin polymerisation [20]. ",
      "key": "355c8649a48767075b911e51544b4355f914655f67236ad26feacc6a7a32243ec3898fceacfa8afaa68eb5720ca41dc93fdd069e644081819f4295c07f62b41b",
      "line": 175,
      "relation": "decreases",
      "source": 9,
      "target": 26
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Microglia": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "name": "Acta neuropathologica",
        "pages": "819-838",
        "reference": "28803412",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "type": "PubMed",
        "volume": "134"
      },
      "evidence": "Golgi fragmentation has also been observed as a result of oligomers formed by over-expression of a-syn in COS-7 cells [55].",
      "key": "2fc85fc23f534066810c14a76a72e243989e4120353a29be36e3829173a9948d01dc1ba857857b542344e2041e18f88db492c702ed92fa732194d2a453fb70d5",
      "line": 179,
      "relation": "decreases",
      "source": 9,
      "target": 12
    },
    {
      "annotations": {
        "Cell": {
          "neuron": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "name": "Acta neuropathologica",
        "pages": "819-838",
        "reference": "28803412",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "type": "PubMed",
        "volume": "134"
      },
      "evidence": " In contrast, a-syn 30–110 that forms fibrils at a fast rate, did not display toxicity, indicating that oligomers are indeed the toxic species leading to TH-neuron loss in vivo [162].",
      "key": "5da233f42e9fa5f4b8c9d1dc147907e43a981e1ebcfb6ebe81e409d2d11e45906fb5138cb1f28458a24faf98e83f566c2d236fbe6c13d65d6fccadce97fae01c",
      "line": 83,
      "relation": "causesNoChange",
      "source": 8,
      "target": 17
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Microglia": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "name": "Acta neuropathologica",
        "pages": "819-838",
        "reference": "28803412",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "type": "PubMed",
        "volume": "134"
      },
      "evidence": " a report by Hoffmann et al. showed that fibrillar a-syn induced a more pronounced inflammatory response in microglial cells [61].",
      "key": "08f6737d89cd14149c2da04906da2fc800fd0b61b26889f18f6a6a272895e59157fbbb18bc04b8acef2394158b138564ada250c6119d2640d8b4e2f452bc3008",
      "line": 125,
      "relation": "increases",
      "source": 8,
      "target": 19
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Microglia": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "name": "Acta neuropathologica",
        "pages": "819-838",
        "reference": "28803412",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "type": "PubMed",
        "volume": "134"
      },
      "evidence": " a report by Hoffmann et al. showed that fibrillar a-syn induced a more pronounced inflammatory response in microglial cells [61].",
      "key": "c75c2a1b5719e0bc0ce8df6db2f327daea4ee263f50d9dcd37a74a5ef996a7b6a9c8eeb7764be9ce9b804605be27d8492ed78886a132a7005387c9ca3566f8f5",
      "line": 126,
      "relation": "increases",
      "source": 8,
      "target": 20
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "name": "Acta neuropathologica",
        "pages": "819-838",
        "reference": "28803412",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "type": "PubMed",
        "volume": "134"
      },
      "evidence": " Finally, Parkinson’s disease patients carrying familial mutations in the parkin gene, and some of those with the LRRK2 G2019S mutation, show neuronal degeneration in the absence of Lewy body formation [28, 50]. ",
      "key": "daede0a0a1f1f64674f1767ef05dc7f339f88eeffb52eb2ad6aa829606e5e6038cf1956cc0575ff818553943c0fc8f4855d243a6669cf0fff4162bac182711b7",
      "line": 70,
      "relation": "increases",
      "source": 32,
      "target": 46
    },
    {
      "key": "10487a8d22b323a87b2ef92474948fe9cbbd3497ae38566976f3685b17a3f09a26f540d1004db223ccacd9eef7e6d00a24383486bf7c3f9af7c6e962c6c86f2c",
      "relation": "hasVariant",
      "source": 31,
      "target": 32
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "name": "Acta neuropathologica",
        "pages": "819-838",
        "reference": "28803412",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "type": "PubMed",
        "volume": "134"
      },
      "evidence": " Finally, Parkinson’s disease patients carrying familial mutations in the parkin gene, and some of those with the LRRK2 G2019S mutation, show neuronal degeneration in the absence of Lewy body formation [28, 50]. ",
      "key": "f3fca68f27e5d16b613cf1a09ff3bef20811ff527a909500907db7cfb00d46710f324c7e00340762a4028961cc5c16b9109fb701710a600b45ec15be0614646e",
      "line": 71,
      "relation": "increases",
      "source": 30,
      "target": 46
    },
    {
      "key": "99c77f525143a54c34cd284711ced224797205a7c349bb13a00c2cd3202979f2d775f98ae2cd4eb4dd6e6e66e969b41335cc987dc70526200b480e8b3da7c074",
      "relation": "hasVariant",
      "source": 29,
      "target": 30
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "name": "Acta neuropathologica",
        "pages": "819-838",
        "reference": "28803412",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "type": "PubMed",
        "volume": "134"
      },
      "evidence": " Interestingly, it was very recently reported that astrocytes take up a-syn oligomers and degrade it via the lysosomal pathway, but this pathway can become saturated leading to mitochondrial fragmentation [89]. ",
      "key": "5c1b8ad9f463d978adff1618eb29d208f93ba786ae71bf01194e435b59e4839462d32d33e54096c5755b1f31ee47f1aecc6f37826365fee922a49ec02430cf9a",
      "line": 94,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 13,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "name": "Acta neuropathologica",
        "pages": "819-838",
        "reference": "28803412",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "type": "PubMed",
        "volume": "134"
      },
      "evidence": "furthermore, treatment with salubrinal, which alleviates ER stress, reduced oligomeric accumulation in the ER.",
      "key": "11b013466448366552cbe1c5203f3cc8c208ac4d4c2135f0bc6c3a0ab004a2ac5e27cf70edc0d458b98082178a39fb47b5455e723433160dde89e9a8b6d24381",
      "line": 107,
      "relation": "decreases",
      "source": 4,
      "target": 23
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Endoplasmic Reticulum": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "name": "Acta neuropathologica",
        "pages": "819-838",
        "reference": "28803412",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "type": "PubMed",
        "volume": "134"
      },
      "evidence": "furthermore, treatment with salubrinal, which alleviates ER stress, reduced oligomeric accumulation in the ER.",
      "key": "c0353cce0c2ee26b8d8e3972caaeeb0504dc273c6b8aa1d95d778f7c2edf98dbcda86c3f07589f290ad429c8ad5f425b0bded3aedfeec97a048947e14d12c9bd",
      "line": 109,
      "relation": "decreases",
      "source": 4,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Endoplasmic Reticulum": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "name": "Acta neuropathologica",
        "pages": "819-838",
        "reference": "28803412",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "type": "PubMed",
        "volume": "134"
      },
      "evidence": "Finally, inhibition of histone deacetylase 6 (HDAC6), which was previously shown to be involved in the response to cytotoxic ubiquitinated aggregates, increased the oligomeric content in vitro, while overexpression of HDAC6 produced the opposite effect [36]. ",
      "key": "cbf3f0f4bd28fc8562d557f902c6a645fb12f062392a027990e4b76d74ab1af267b8611672e2a9e7be8183904f4e59a993c4b84a55538d6dc739c8a56b75a15a",
      "line": 120,
      "relation": "decreases",
      "source": 28,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Microglia": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "name": "Acta neuropathologica",
        "pages": "819-838",
        "reference": "28803412",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "type": "PubMed",
        "volume": "134"
      },
      "evidence": "a-syn accumulation has been linked to autophagic and lysosomal dysfunction, which may in turn lead to a-syn aggregation and production of more detrimental oligomers. ",
      "key": "b3416e1600482bf4ee71fffb6330f6686dbc5c254f811a67bb3bad2695c75ff3adb200b9761a9672fb7180a6ba6af476492d41c97aa486219d83b2ee599d4131",
      "line": 157,
      "relation": "increases",
      "source": 22,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Microglia": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "name": "Acta neuropathologica",
        "pages": "819-838",
        "reference": "28803412",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "type": "PubMed",
        "volume": "134"
      },
      "evidence": "Accordingly, overexpression of transcription factor EB (TFEB) was shown to correct lysosomal defects induced by the viral overexpression of a-syn and to downregulate the accumulation of oligomers in vivo [32]. ",
      "key": "7dc420a09d5d6e8246068e6e9f4c5e0782bcb98a0fadcd1a124316e808a86383d095978787f6fe5fc716e742f13ba9fb06085743b884343f81986c1d5325516e",
      "line": 162,
      "relation": "decreases",
      "source": 40,
      "target": 9
    },
    {
      "key": "ba264b4c634d3b8235c6b1b7591af9f148d0b28f00883e49ca1813913d77d5d8980a02baddc88a3765fdb819d3c23be195dc15783c2957b42fa877dbbe786afe",
      "relation": "hasComponent",
      "source": 25,
      "target": 9
    },
    {
      "key": "b152e11785f67c045abc276eaed50799bff83439542bded5ab5d516177c48b81ccaefb78983fa3c036226ff94083af0ccc487c2e945dfc38b867d697d66019f0",
      "relation": "hasComponent",
      "source": 25,
      "target": 43
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Microglia": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "name": "Acta neuropathologica",
        "pages": "819-838",
        "reference": "28803412",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "type": "PubMed",
        "volume": "134"
      },
      "evidence": " First, a-syn oligomers bind synaptobrevin, a component of the SNARE complex required for synaptic vesicle fusion, and prevent the formation of the SNARE complex [23]. ",
      "key": "a9cc13dfecdab5149968a9fa0639205c5408d1dc09cf2bdbe4cfc3da56b50c73e540f723b16fdeacba24430f3949f2abbeeeb1fede720759634db5c8939d9a7c",
      "line": 167,
      "relation": "decreases",
      "source": 25,
      "target": 16
    },
    {
      "key": "12c81f586776542e89b325cf4249de0b20e376f60910d0fd2a80e6676263122e6b6371557ed3e6501f0c6e6852c9f37c8a7e9cf8296f99971c38a189db1578ef",
      "relation": "hasComponent",
      "source": 26,
      "target": 10
    },
    {
      "key": "346fad8d878375e6fa818413431c835369be31f71b0da9659e94bcff572ca482e6ce31469d0ba8b887494fc1c23030d5482950b59dcec88972670b7e4302bfc9",
      "relation": "hasComponent",
      "source": 26,
      "target": 14
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Microglia": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "name": "Acta neuropathologica",
        "pages": "819-838",
        "reference": "28803412",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "type": "PubMed",
        "volume": "134"
      },
      "evidence": "USP19 promoted the secretion of a-syn, suggesting that MAPS is an unconventional secretion pathway utilized by a-syn, particularly under conditions of proteasomal impairment, which has been repeatedly linked to Parkinson’s disease. ",
      "key": "a4ced91192622f07363d63f70576b22326b3dfd8455d09d86d082746ef887abcf79385400ac6ebf545cd8587121897e1d6ba969507c0a598d3a9ff1a063c7ef9",
      "line": 184,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 42,
      "target": 33
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true,
          "Cerebrospinal Fluid": true,
          "Serum": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "name": "Acta neuropathologica",
        "pages": "819-838",
        "reference": "28803412",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "type": "PubMed",
        "volume": "134"
      },
      "evidence": " In vitro studies have shown that curcumin inhibited the formation of fibrils and disaggregated amyloid-beta and a-syn [112, 114, 155].",
      "key": "6e28b1e4f53aff4daa4127656529ff251eec47a13d08a8208cdf248188b23c863327a872ce30fc4d35bf8c9145d20625fc43fc67283c249b9fdb8dd3a21497bf",
      "line": 198,
      "relation": "decreases",
      "source": 3,
      "target": 8
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true,
          "Cerebrospinal Fluid": true,
          "Serum": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "name": "Acta neuropathologica",
        "pages": "819-838",
        "reference": "28803412",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "type": "PubMed",
        "volume": "134"
      },
      "evidence": " In vitro studies have shown that curcumin inhibited the formation of fibrils and disaggregated amyloid-beta and a-syn [112, 114, 155].",
      "key": "d4c67577517e3bd137e6abb3b1db06bb44685b22bfa9392c3cdc9d8c33c62e493f5129d5c1aa9d061ce73757fc4ae2ab8131793bea3f4eff4502d5c680bf8573",
      "line": 199,
      "relation": "decreases",
      "source": 3,
      "target": 5
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true,
          "Cerebrospinal Fluid": true,
          "Serum": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "name": "Acta neuropathologica",
        "pages": "819-838",
        "reference": "28803412",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "type": "PubMed",
        "volume": "134"
      },
      "evidence": " In vitro studies have shown that curcumin inhibited the formation of fibrils and disaggregated amyloid-beta and a-syn [112, 114, 155].",
      "key": "dbbde115695705a15d439d009294a8461404b8e47cae8319015ab3813af3506d33b2f1fa696ec5b16527e4749341d2d9a46c1d500519fd5aa27771da904fe3fb",
      "line": 200,
      "relation": "decreases",
      "source": 3,
      "target": 7
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true,
          "Cerebrospinal Fluid": true,
          "Serum": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "name": "Acta neuropathologica",
        "pages": "819-838",
        "reference": "28803412",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "type": "PubMed",
        "volume": "134"
      },
      "evidence": "Epigallocatechin-3-gallate (EGCG), a small molecule that been shown to inhibit the aggregation of several amyloidogenic proteins such as a-syn, amyloid-beta and huntingtin [9, 37, 38, 105] binds to unfolded native amyloid-beta and a-syn and promotes the formation of nontoxic oligomers that do not convert into amyloid fibrils [37]. ",
      "key": "07a0d08ae20753a5ab8d3a0828038bcac84786a82a7627cc995f4493dd4b2b1881f92378c16183806aabb7c516518e7fc4e0bd0a817e1435ed54feeb9c0e4026",
      "line": 206,
      "relation": "decreases",
      "source": 0,
      "target": 5
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true,
          "Cerebrospinal Fluid": true,
          "Serum": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "name": "Acta neuropathologica",
        "pages": "819-838",
        "reference": "28803412",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "type": "PubMed",
        "volume": "134"
      },
      "evidence": "Epigallocatechin-3-gallate (EGCG), a small molecule that been shown to inhibit the aggregation of several amyloidogenic proteins such as a-syn, amyloid-beta and huntingtin [9, 37, 38, 105] binds to unfolded native amyloid-beta and a-syn and promotes the formation of nontoxic oligomers that do not convert into amyloid fibrils [37]. ",
      "key": "6f8c80bf9273f8ba567508bd44498b4af4b0a8ae47c40341e3e9fea7048dceac50edfd79cad4b9ec345f6d6d4821c57f8828a7971c9d5333cc4a04ce9f8998e4",
      "line": 207,
      "relation": "decreases",
      "source": 0,
      "target": 7
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true,
          "Cerebrospinal Fluid": true,
          "Serum": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "name": "Acta neuropathologica",
        "pages": "819-838",
        "reference": "28803412",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "type": "PubMed",
        "volume": "134"
      },
      "evidence": "Epigallocatechin-3-gallate (EGCG), a small molecule that been shown to inhibit the aggregation of several amyloidogenic proteins such as a-syn, amyloid-beta and huntingtin [9, 37, 38, 105] binds to unfolded native amyloid-beta and a-syn and promotes the formation of nontoxic oligomers that do not convert into amyloid fibrils [37]. ",
      "key": "d6e6d024a1a418685fdb644192296448bade805ca4c8b6bc0753d7fd3495de176f74bab21b263eed5eeddef5f9a3e34d5f2c65ffbe0326976c8b775291f5e3b8",
      "line": 208,
      "relation": "decreases",
      "source": 0,
      "target": 6
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true,
          "Cerebrospinal Fluid": true,
          "Serum": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "name": "Acta neuropathologica",
        "pages": "819-838",
        "reference": "28803412",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "type": "PubMed",
        "volume": "134"
      },
      "evidence": "Prabhudesai et al. showed that this molecule is able to inhibit the aggregation of a-syn in vitro and in a zebrafish model expressing human wild-type a-syn in neurons where CLR01 reduced apoptosis and improved embryo survival [127]. ",
      "key": "8e3d4a6b4bd301cfac33483aca70ee7958f120c73ff418f3c61fd9254808fad2f78c5c463106ebc95def151aa239be2091fac723f1401bd46cfec92cac5bb02c",
      "line": 213,
      "relation": "decreases",
      "source": 27,
      "target": 5
    },
    {
      "annotations": {
        "Cell": {
          "neuron": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true,
          "Cerebrospinal Fluid": true,
          "Serum": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "first": "Bengoa-Vergniory N",
        "last": "Alegre-Abarrategui J",
        "name": "Acta neuropathologica",
        "pages": "819-838",
        "reference": "28803412",
        "title": "Alpha-synuclein oligomers: a new hope.",
        "type": "PubMed",
        "volume": "134"
      },
      "evidence": "Prabhudesai et al. showed that this molecule is able to inhibit the aggregation of a-syn in vitro and in a zebrafish model expressing human wild-type a-syn in neurons where CLR01 reduced apoptosis and improved embryo survival [127]. ",
      "key": "3201681061ac87f95e0ef30c4f1ba89195e3e6147e9eb18d33af98425d2b638c905fe84b6e1690547052e942fbac3b965415eecc78a8df6a80fc8ddf85760ce8",
      "line": 215,
      "relation": "decreases",
      "source": 27,
      "target": 17
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CHEBI:\"(-)-epigallocatechin 3-gallate\")",
      "function": "Abundance",
      "id": "6ab1c80d3de724e6d924795da884f193d598624c7407acbe86dd59da673081130206c19bcf6637d2372ba76d86fdbe737a1dff9f7a9b685fb82284147388c222",
      "name": "(-)-epigallocatechin 3-gallate",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:\"calcium(2+)\")",
      "function": "Abundance",
      "id": "4fb8648e4c5fea95cea6a46291d28175bba677d8b6fa8d607b1febef51c8370cbc1ff98d09312dc418ff31d04177d26f231d4f0a1a963f43fbc29cfb3269d3c9",
      "name": "calcium(2+)",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:\"reactive oxygen species\")",
      "function": "Abundance",
      "id": "5da7879846ec42231f9176e97a7f14c4b573807576fa75be6e3acb71f391f25971e33d2f7fb886003ebd8020ab592e1424e2fc106f91213d546078dd09fabb65",
      "name": "reactive oxygen species",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:curcumin)",
      "function": "Abundance",
      "id": "a784cb1e1965d09b2812ceaada10e172836399f6b72ec8154a36346d212255f49d8ae319b42578ea1c29fe7b4f04e3396e963011eb98b928bfd624dfd7fa8787",
      "name": "curcumin",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:salubrinal)",
      "function": "Abundance",
      "id": "457881eba6833d5b6664d368417fb2aeeb44409089023dcba70fe5bc8cde8569c3ad606e71011e9cfc3a68cd45d47b3e95021152fbd11d3bc9fe443f4350c304",
      "name": "salubrinal",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CONSO:CONSO00016)",
      "function": "Abundance",
      "id": "f66e51f74a3a6674f536fb6da4bed87a17436ccfea5397bfa2b7cd97eed7d5cf5c30c453444a583a3bcfe21a71f7b5b527d958de3da467339cb3a709f36ff1ac",
      "name": "CONSO00016",
      "namespace": "CONSO"
    },
    {
      "bel": "a(CONSO:CONSO00017)",
      "function": "Abundance",
      "id": "f66f024057bce60c669aefc93554fb0f34f5056ceb6ca8c06004c46bfe9ea51fcd06c4e296e5d2885b8f558d58481187133915136aa7378d10d3e1fd12479e7f",
      "name": "CONSO00017",
      "namespace": "CONSO"
    },
    {
      "bel": "a(CONSO:CONSO00018)",
      "function": "Abundance",
      "id": "03851dfd7175733b6351f4ebbc7209b124a5f9252b750089760cfbce516ab1044d662f2e161bef80676c4a9ee4274c54687287f6cc5fe54523326e97a130a444",
      "name": "CONSO00018",
      "namespace": "CONSO"
    },
    {
      "bel": "a(CONSO:CONSO00092)",
      "function": "Abundance",
      "id": "a509572039606ca7f1549be9495e67009e9e7523165f448976278dacccebbc8bf9364a8261abde146a21c30a4e44b77320ef7aec57cd0f926cc80fa6eeb1dc31",
      "name": "CONSO00092",
      "namespace": "CONSO"
    },
    {
      "bel": "a(CONSO:CONSO00093)",
      "function": "Abundance",
      "id": "a86407e103868c252cdaffc734043296cad46636910adec961233e77b3fa0ebcd2421bf51f2e8f7d4569dc633b7a9d1aba70221b2c6be2cdc66b0f074e885f05",
      "name": "CONSO00093",
      "namespace": "CONSO"
    },
    {
      "bel": "a(GO:microtubule)",
      "function": "Abundance",
      "id": "0c753f37efe0eb149a47a1dd700eda093a03b462374275c68480b6aed3be0f81aa9793a179dfd97f8e0834f1fb9be4b4a6cff2165b176d9e8a8744f5e0d5bc2c",
      "name": "microtubule",
      "namespace": "GO"
    },
    {
      "bel": "a(MESH:\"Cell Membrane\")",
      "function": "Abundance",
      "id": "01ec7ffbcb8c9179057e9b0566861267a0a59f1b56f279101da5015908500b307bc7b168ef6d6540548d8fe99dd18a44e972e1682631a179a440ad4e5f662b4a",
      "name": "Cell Membrane",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:\"Golgi Apparatus\")",
      "function": "Abundance",
      "id": "15023fd7dc520e9f7d90ed3ec1377ce46afb06bc6122dc6d4f7fee5c96668164f10c6bb016f8a67b3f79d1cdc890c060663ca493e374303855b31ad2910a0187",
      "name": "Golgi Apparatus",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:Astrocytes)",
      "function": "Abundance",
      "id": "fde64edccc2d2516ac85472bd1b91641459a78f34e06f497636f2c401c2df220b9a929108658f0d9c4b8091c3bb917ecf96b52133a312a439d8370e834a2ef91",
      "name": "Astrocytes",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:Kinesin)",
      "function": "Abundance",
      "id": "e0b5860aa8a6680103e27982b3a6ac2cabfb24cd338360586c07e8918ec6bbb2eb20fce39105e2ac0a12c90ba494694d4e2d588e60f10e13bb44d056b8257e0a",
      "name": "Kinesin",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:Mitochondria)",
      "function": "Abundance",
      "id": "8239d19592a7e8cb8a527e24faaa0525a4e648d810d9bf5a43a163754e30e3c96fb63ce1c21e2a445871a5b231d04c1852723d5b756f0b7276343cc13d48e781",
      "name": "Mitochondria",
      "namespace": "MESH"
    },
    {
      "bel": "bp(GO:\"SNARE complex assembly\")",
      "function": "BiologicalProcess",
      "id": "9506343118b89e3c2d0f6096737619c09ae10443020ba8824d5c042ed7464f007435e93f03b8eefcdc590601c7efaef863b3a8fac45866e006426f88ee882124",
      "name": "SNARE complex assembly",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"apoptotic process\")",
      "function": "BiologicalProcess",
      "id": "1c5172472cbecf29eeb8e86a4cac2d13123fe572356f00e2f98302422560bbda2854e3b1f8fdf85396655393cf5ddb42e0db210c3d3fc146fa358cc8d0ed0254",
      "name": "apoptotic process",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"axonal transport\")",
      "function": "BiologicalProcess",
      "id": "05b46e2a47c4835f765deb7eb33b970b7abbb53b690b7881e2beda6bc739337253a12aaafa51ebf63ed9f7ad7f09bcd7f5ce4fda7373ed3f4f0eadedaf2c14d0",
      "name": "axonal transport",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"inflammatory response\")",
      "function": "BiologicalProcess",
      "id": "422dfc2db00b1d942862470cbabe1e8312bf97b25050190db5ae19636adae95f4fa18c512574526825bd377b16c2278899435eb759e951ba850ad476e14f9900",
      "name": "inflammatory response",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"microglial cell activation\")",
      "function": "BiologicalProcess",
      "id": "9e9682b78aa06bbcb9dae35006f6da468e11928c000097001cd665b1bedf3c75ef887ecd7781ef3c545cafb3780cb7afabec9bfc70e14a48149d8adee8502981",
      "name": "microglial cell activation",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"synaptic vesicle transport\")",
      "function": "BiologicalProcess",
      "id": "8b8d69e34abfbe32312eb0ab0f121d348adb58dfdcd7285c3984edcc6370f78c9195e09fe526096f94e4bd138017c0e0a3144c7cf780788a2fc7d38856b0a3d1",
      "name": "synaptic vesicle transport",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:autophagy)",
      "function": "BiologicalProcess",
      "id": "f1a3202be460e565f65c1445ee061e99f63cc05f9ab70c5d4d8d93ba180d6a94f65cb8d1ac6c5ba53c0a4d2e153db32135e6a0bffcfdfd4d84e6727594a70b0a",
      "name": "autophagy",
      "namespace": "GO"
    },
    {
      "bel": "bp(MESH:\"Endoplasmic Reticulum Stress\")",
      "function": "BiologicalProcess",
      "id": "89273f58f970a9467557f020ba5f5af7f8eb84045d0b1fb2eeba697d56475fcb2dae9019025a1d89fab2cba9466474067ed76af341294164c040dcb7b6e90507",
      "name": "Endoplasmic Reticulum Stress",
      "namespace": "MESH"
    },
    {
      "bel": "complex(GO:\"proteasome complex\")",
      "function": "Complex",
      "id": "5deb6bcfdcfa66f95c4979205b8144cf23a26c8da492c2d4b71750a7f8e440a3d40a37452d67ccbdccfba2bd5cea7bf1bbba3d66e18875bae3fd8abd8d3d68f4",
      "name": "proteasome complex",
      "namespace": "GO"
    },
    {
      "bel": "complex(a(CONSO:CONSO00093), p(HGNC:VAMP1))",
      "function": "Complex",
      "id": "09c5670122452fdb730eee3819a73730d65ab28b7c4f2a6963e9a69d2be4615670b3091754e9cddc2cbd223b43be48fe52e0b03f6b5e07a9f14f3326224d499d",
      "members": [
        {
          "bel": "a(CONSO:CONSO00093)",
          "function": "Abundance",
          "id": "a86407e103868c252cdaffc734043296cad46636910adec961233e77b3fa0ebcd2421bf51f2e8f7d4569dc633b7a9d1aba70221b2c6be2cdc66b0f074e885f05",
          "name": "CONSO00093",
          "namespace": "CONSO"
        },
        {
          "bel": "p(HGNC:VAMP1)",
          "function": "Protein",
          "id": "f866c8c3beb7dc9a3deceb4135a5856f9b31c4daefff479793aae0a6e88e32d15d6890378f21f748cd932c409148e7b7afe8e612a02fb4c2409e905fcb1fd455",
          "name": "VAMP1",
          "namespace": "HGNC"
        }
      ]
    },
    {
      "bel": "complex(a(GO:microtubule), a(MESH:Kinesin))",
      "function": "Complex",
      "id": "729993ccf92e3e5ccd2560b53ad69a0d0f6f84061fa3965c7e5a3551288df497093b4e67f3cd1c600b24dbb9f155db8fed8246921af89f521d1e69ed6b69b1fe",
      "members": [
        {
          "bel": "a(GO:microtubule)",
          "function": "Abundance",
          "id": "0c753f37efe0eb149a47a1dd700eda093a03b462374275c68480b6aed3be0f81aa9793a179dfd97f8e0834f1fb9be4b4a6cff2165b176d9e8a8744f5e0d5bc2c",
          "name": "microtubule",
          "namespace": "GO"
        },
        {
          "bel": "a(MESH:Kinesin)",
          "function": "Abundance",
          "id": "e0b5860aa8a6680103e27982b3a6ac2cabfb24cd338360586c07e8918ec6bbb2eb20fce39105e2ac0a12c90ba494694d4e2d588e60f10e13bb44d056b8257e0a",
          "name": "Kinesin",
          "namespace": "MESH"
        }
      ]
    },
    {
      "bel": "p(CONSO:CONSO00094)",
      "function": "Protein",
      "id": "9407f9aa429660cc49b439f03f44d04436680f70f1f9d2d92e2cf1e51878ac2f266479c93392671ee264164e4a17b998b8936fc23162aeba818d1e29744dcfd3",
      "name": "CONSO00094",
      "namespace": "CONSO"
    },
    {
      "bel": "p(HGNC:HDAC6)",
      "function": "Protein",
      "id": "c6e2cb3c91ba614ec9e19574656eba9d234344b755f57479d99a4d4ff77acc4917594446b9b19f9823e8a8a0d2d457d74b6f6a582d9f360f13df4136d902c7c3",
      "name": "HDAC6",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:LRRK2)",
      "function": "Protein",
      "id": "f96ead302c9d5f0deee787cbc3ab3b9a683a4c41955ca6520d12263f2bfbc9810e87220fbe1c64675505d5e699f6e802c656ce2a11fb5936f0670423987e141e",
      "name": "LRRK2",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:LRRK2, var(\"p.Gly2019Ser\"))",
      "function": "Protein",
      "id": "09ee74ee2a3f69d927906657662555caabdffd619da7a6d21bf8499552c71e8639645a1f42dedaaaaa5a5f23b047a789e3a6e6222552b05bea22aff6b4de765b",
      "name": "LRRK2",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": "p.Gly2019Ser",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:PRKN)",
      "function": "Protein",
      "id": "c129e31246d9b635f2d39f8a0d20e11d29724b9888bc1c35e5b5f5eb721f42a8ead8ccee052e21a3c178f79c19d2fecb3360bd35d0a89f449b2d05af14ae324f",
      "name": "PRKN",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:PRKN, var(\"?\"))",
      "function": "Protein",
      "id": "18bad2008a5318b2ac88e39192c1cdc3930229cde4d1875cba179e0c144b7ee324191837819b0e6294790388cc7e202eca06b5776e5def8f36b099e366069eb1",
      "name": "PRKN",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": "?",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:SNCA)",
      "function": "Protein",
      "id": "4345441d1f420dc0d830377737dba9467f21b1637ed3472a697534ce698f2566b780dd52cda47c96b782242b1bcfa70e9a6147fb3bb251d1f3e1e2a0bb7038f3",
      "name": "SNCA",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:SNCA, var(\"p.Ala30Pro\"))",
      "function": "Protein",
      "id": "56ce8be3c490eafefc734158205e27bfcde01c5d160354345ad61607099ca26704f9f079559cf958aa16b1ae1fffafd552ddabf79ecf722d81d7b3ec047ff1be",
      "name": "SNCA",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": "p.Ala30Pro",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:SNCA, var(\"p.Ala53Glu\"))",
      "function": "Protein",
      "id": "0d233111c4dae7c6056cc60649172e409e279dbcbd11e48431b9ce42bce5324e5b2295d2f82d7485a5b512c56645c4beaa7536a4fbed666bc7954f8d479e2885",
      "name": "SNCA",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": "p.Ala53Glu",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:SNCA, var(\"p.Ala53Thr\"))",
      "function": "Protein",
      "id": "d2068443e7a690d5d02ecf646516124d655e615c8f4a7c320cad114af8b6cb752bcdb98e8973c053690af90c8cb72d8d4211d4f8f1314c79c1aab0bbd385c692",
      "name": "SNCA",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": "p.Ala53Thr",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:SNCA, var(\"p.Glu46Lys\"))",
      "function": "Protein",
      "id": "99c3c9b0570d65ca12c2d36d1e2aeeefedf4f40a296686aec6d52be37a2ea6b4917239dd3ced7341e83742aeefe3170916f8b0fb876378a0b959b394798d64b6",
      "name": "SNCA",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": "p.Glu46Lys",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:SNCA, var(\"p.Gly51Asp\"))",
      "function": "Protein",
      "id": "c16c0366121175c5181c6386d1999a0e1c38c489590b03be38c892975db2a4c7715522ebda43545cb5eb7710b046fa9a6698ed1f2301172b1427051a9bcc49ac",
      "name": "SNCA",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": "p.Gly51Asp",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:SNCA, var(\"p.His50Gln\"))",
      "function": "Protein",
      "id": "d092739935db44b23cca1da78eafc19242be4ac684ac904de8184eafe23490dc65e533b306826e9e80b3263796879c3630190bcbf6212d6f0e403539b9531cdf",
      "name": "SNCA",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": "p.His50Gln",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:TFEB)",
      "function": "Protein",
      "id": "d2586deea41500a6ea7755a94475bef3e256337b994748bb58034e8a43261cfea2cf38bc85241d08d9e06bdfc15b92df32297bceb6a3bf8848c3f2d6878b030b",
      "name": "TFEB",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:TLR2)",
      "function": "Protein",
      "id": "0f6907265dc069929af65d69b22bf45e32c22dae9b37b9e2a46bfe52b79bc136835507187a3f3e80a7062f116acfc44532ab9bc11456d8ac5fc143b327274b25",
      "name": "TLR2",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:USP19)",
      "function": "Protein",
      "id": "9e2f6022d4589721d0683b2ed23f6867213b72915c7b662824d0597d651ba4d266ec8793e753799e2af1916efaf66f6c969fc717ace6884efee04dfa1625ca6d",
      "name": "USP19",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:VAMP1)",
      "function": "Protein",
      "id": "f866c8c3beb7dc9a3deceb4135a5856f9b31c4daefff479793aae0a6e88e32d15d6890378f21f748cd932c409148e7b7afe8e612a02fb4c2409e905fcb1fd455",
      "name": "VAMP1",
      "namespace": "HGNC"
    },
    {
      "bel": "path(CONSO:CONSO00037)",
      "function": "Pathology",
      "id": "e287cdeca5da7452f9ef123661f7e7e7f7daeb8d183bca2a87a34f00eb110777519f087b3a359523429489d51d278700e335d943de5cbbbe8feca894f5ae1c99",
      "name": "CONSO00037",
      "namespace": "CONSO"
    },
    {
      "bel": "path(MESH:\"Lewy Body Disease\")",
      "function": "Pathology",
      "id": "96e3a681a3c1aae0a3a2b158907153fc5e976e52d355cfecb0af2b5ab767bda982ed8c11b147dcfb04800986cc50e61613c751e724d8259e7863ae31adfd78f1",
      "name": "Lewy Body Disease",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:\"Neurodegenerative Diseases\")",
      "function": "Pathology",
      "id": "95863a6d11beb3bd993523e1c8c7e210d281b0c092553f6a4cf27dd3ecf2fa51b49c5056b8aed6f7ac7c82f99101c34bc9fc0afc3dce117fe011d159ba9e4c89",
      "name": "Neurodegenerative Diseases",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:\"Parkinson Disease\")",
      "function": "Pathology",
      "id": "d7f039170f83b3fcc27595412f3b0352cd1fe95f8481a2b1144ce311ac81bb5f0087a0a7e682f498d193e00b8e8fb29908a6e0b8e23da5ef349aeeb4723b9be0",
      "name": "Parkinson Disease",
      "namespace": "MESH"
    }
  ]
}